Gilead Sciences, Inc. (NASDAQ:GILD)
CAPS Rating:
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
Taking it to the street
A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Good fundamentals. Support at $36 and turning up. Will also be a good defensive play when the general market corrects.